Magnesium in PDB 4eop: Thr 160 Phosphorylated CDK2 Q131E - Human Cyclin A3 Complex with the Inhibitor RO3306

All present enzymatic activity of Thr 160 Phosphorylated CDK2 Q131E - Human Cyclin A3 Complex with the Inhibitor RO3306:
2.7.11.22;

The structure of Thr 160 Phosphorylated CDK2 Q131E - Human Cyclin A3 Complex with the Inhibitor RO3306, PDB code: 4eop was solved by A.Echalier, E.Cot, A.Camasses, E.Hodimont, F.Hoh, F.Sheinerman, L.Krasinska, D.Fisher, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å)	29.83 / 1.99
Space group	P 21 21 21
Cell size a, b, c (Å), α, β, γ (°)	74.780, 133.390, 147.680, 90.00, 90.00, 90.00
R / Rfree (%)	21.6 / 24.1

The binding sites of Magnesium atom in the Thr 160 Phosphorylated CDK2 Q131E - Human Cyclin A3 Complex with the Inhibitor RO3306 (pdb code 4eop). This binding sites where shown within 5.0 Angstroms radius around Magnesium atom.
In total only one binding site of Magnesium was determined in the Thr 160 Phosphorylated CDK2 Q131E - Human Cyclin A3 Complex with the Inhibitor RO3306, PDB code: 4eop:

Magnesium binding site 1 out of 1 in the Thr 160 Phosphorylated CDK2 Q131E - Human Cyclin A3 Complex with the Inhibitor RO3306


Mono view


Stereo pair view

A full contact list of Magnesium with other atoms in the Mg binding site number 1 of Thr 160 Phosphorylated CDK2 Q131E - Human Cyclin A3 Complex with the Inhibitor RO3306 within 5.0Å range: probe atom residue distance (Å) B Occ D:Mg501 b:29.0 occ:1.00 O D:GLN203 2.2 31.8 1.0 O D:HOH642 2.2 29.6 1.0 O D:ILE206 2.2 31.7 1.0 O D:MET200 2.2 34.2 1.0 C D:GLN203 3.3 31.5 1.0 C D:MET200 3.4 33.4 1.0 C D:ILE206 3.5 30.8 1.0 CB D:GLN203 3.9 27.5 1.0 CG D:MET200 4.0 33.6 1.0 CA D:GLN203 4.0 30.0 1.0 N D:GLN203 4.2 31.1 1.0 CA D:MET200 4.3 32.3 1.0 CA D:THR207 4.3 30.8 1.0 N D:THR207 4.3 30.3 1.0 N D:LYS201 4.4 35.5 1.0 N D:ILE206 4.4 32.0 1.0 N D:PRO204 4.5 33.9 1.0 CA D:ILE206 4.5 31.6 1.0 CA D:LYS201 4.5 38.2 1.0 O D:HOH673 4.6 34.5 1.0 CG2 D:THR207 4.6 31.4 1.0 CB D:MET200 4.6 32.4 1.0 SD D:MET200 4.6 33.5 1.0 O D:HOH641 4.7 31.8 1.0 C D:LYS201 4.7 38.4 1.0 C D:PRO204 4.8 34.9 1.0 CA D:PRO204 4.8 34.8 1.0 O D:LYS201 4.9 39.9 1.0

A.Echalier, E.Cot, A.Camasses, E.Hodimont, F.Hoh, P.Jay, F.Sheinerman, L.Krasinska, D.Fisher. An Integrated Chemical Biology Approach Provides Insight Into CDK2 Functional Redundancy and Inhibitor Sensitivity. Chem.Biol. V. 19 1028 2012.
ISSN: ISSN 1074-5521
PubMed: 22921070
DOI: 10.1016/J.CHEMBIOL.2012.06.015